PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsShock
MeSH D012769 - shock
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D010335:Pathologic processes
0 Companies
0 Drugs
Success rate
D012769: 
Shock
92 Companies
18 Drugs
$
Success rate
D009102:Multiple organ failure
1 Company
1 Drug
$
Success rate
D012770:Cardiogenic shock
24 Companies
4 Drugs
$
Success rate
D012771:Hemorrhagic shock
30 Companies
3 Drugs
$
Success rate
D012773:Surgical shock
0 Companies
0 Drugs
Success rate
D012774:Traumatic shock
0 Companies
0 Drugs
Success rate
D018746:Systemic inflammatory response syndrome
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
A.H. Robins CompanyHydrocortisone Hydrocortisone  1982-01-01   
Abbott BiotherapeuticsHydrocortisone A-hydrocort  1982-01-01   
Dopamine Dopamine  1989-01-24   
Able LaboratoriesHydrocortisone Hemsol-hc  1992-06-19   
AllerganHydrocortisone Aeroseb-hc  1982-01-01   
Hydrocortisone Penecort  1984-06-06   
Hydrocortisone Acetasol  1982-01-13   
Hydrocortisone Hydrocortisone  1982-01-01   
Hydrocortisone butyrate Hydrocortisone Butyrate  2017-12-08   
Hydrocortisone, Neomycin, Polymyxin b Otocort  1982-01-01   
AlpharmaHydrocortisone Hydrocortisone  1982-06-07   
AltanaHydrocortisone, Bacitracin, Neomycin, Polymyxin b Bacitracin-neomycin-polymyxin W/ Hydrocortisone  1982-01-01   
Hydrocortisone Hydrocortisone  1982-01-01   
American RegentDopamine Dopamine  1987-02-11   
Amneal PharmaceuticalsNorepinephrine Norepinephrine  2018-12-17   
Amring PharmaceuticalsHydrocortisone, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates Hydrocortisone  2005-10-31   
ANI PharmaceuticalsHydrocortisone Cortenema  1982-01-01   
Hydrocortisone probutate Pandel  1997-02-28   
1
2
3
4
5
6
...
10
>
Clinical Trials
Historical Success Rate
Phase 1
100%
2/2
Phase 2
67%
10/15
Phase 3
63%
17/27
Approved: 8Overall Success rate: 42%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Abbott Biotherapeutics
Hydrocortisone,
Hydrocortisone probutate,
Hydrocortisone butyrate,
Dopamine,
Benzocaine,
Levosimendan,
Mydfrin
Allergan
Hydrocortisone,
Hydrocortisone butyrate,
Hydrocortisone probutate
1
2
3
4
5
6
7
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use